向个性化萨尔布塔摩尔疗法:验证虚拟患者衍生的人口药理动力学模型与现实世界的数据
Lara Marques1,2,3, Nuno Vale1,2,3
1PerMed Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Plácido da Costa, 4200-450 Porto, Portugal.
Pharmaceutics
|July 27, 2024
概括
这项研究开发了一个人群药理动力学 (popPK) 模型,用于治疗喘的药物萨尔布塔摩尔. 该模型确定了患者年龄,性别,种族和体重等因素如何影响萨尔布塔摩尔.
科学领域:
- 药理动力学 药理动力学
- 制药指标 (Pharmacometrics) 是一个指标.
- 喘治疗方法 喘治疗方法
背景情况:
- 治疗反应的个体间变异性受患者特定因素的影响.
- 种群药动力学 (popPK) 建模对于理解剂量-度关系和个性化治疗至关重要.
- 萨尔布塔摩尔是一种短效β2-激动剂 (SABA),广泛用于喘管理.
研究的目的:
- 开发salbutamol的popPK模型,以确定影响其药理学参数的患者特征.
- 通过利用来自生理学基础药理动力学 (PBPK) 模型的合成数据来解决传统临床试验中的数据限制.
- 用真实世界患者数据验证开发的popPK模型.
主要方法:
- 使用PBPK模型生成的合成数据开发salbutamol的popPK模型.
- 在建模过程中包括32名虚拟患者.
- 用真实患者数据对模型进行外部验证.
- 确定影响药理学参数的共变量 (年龄,性别,种族,体重),如清除率 (Cl),区间间清除率 (Q) 和吸收率 (ka).
主要成果:
- 一个具有第一顺序吸收和线性消除的两部分模型提供了最适合萨尔布塔摩尔数据的模型.
- 外部验证证实了预测和观察到的药物度之间的强烈一致.
- 在年龄,性别,种族和体重以及沙布塔摩尔的药理动力学参数之间发现了显著的关联.
- 共变量分析显示年龄影响Cl和Q;性别影响Cl和ka;种族影响Cl;体重影响V2.
结论:
- 该研究成功开发和验证了salbutamol的popPK模型,利用PBPK生成的合成数据来克服临床试验数据挑战.
- 患者的关键特征显著影响萨尔布塔摩尔的药动力学特征,强调需要个性化剂量策略.
- 这些发现支持优化沙布他治疗方案,通过个性化患者护理改善喘管理.
相关概念视频
Analysis of Population Pharmacokinetic Data
244
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
244
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
36
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
36
Pharmacokinetic Models: Comparison and Selection Criterion
64
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
64
Pharmacokinetic Models: Overview
635
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
635
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
66
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
66
One-Compartment Open Model for IV Bolus Administration: General Considerations
178
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
178


